David Knox
Analyst · Cantor
Thank you, Hyunsu. In June of 2025, we set out to establish a new kind of company, one which is blockchain and DeFi native and shares in multiple frontiers of value creation at the same time. Those 3 frontiers include our growing HYPE treasury, our scalable DeFi businesses and our embedded economic upside in the Hyperliquid ecosystem, and we call this our HYPD "Triple-Dip" Strategy. In our 12 months of operating performance, we have redefined what it means to be a digital asset treasury. Not only have we substantially grown our treasury position in HYPE, but we have launched multiple businesses and built new products and services on Hyperliquid, all while reducing our costs over time. As promised since day 1, we are well on our way to becoming a profitable, positive cash-flowing operating company by year-end. Here's our 12-month highlights. Since June of 2025, our gross HYPE tokens have increased 56% from 1.31 million to 2.04 million HYPE tokens. From Q3 '25 to Q2 '26, our quarterly adjusted gross profit has grown 162% from $0.4 million to $1.2 million as our DeFi businesses have begun to ramp. We have consistently earned 2 to 3x base HYPE staking yield over several quarters. Meanwhile, our core operating expenses have declined 46% from $4.3 million to $2.3 million as our legacy biotech segment has been wound down. Also, our quarterly operating cash outflows have declined from $2.8 million to $2.1 million, both as a function of reduced costs and ramping DeFi businesses. Our adjusted gross profit over the past 2 quarters has been 40% to 50% denominated in cash. And we've received equity or token upside in 4 early-stage builders on Hyperliquid, including Kinetiq, HyperLend, Silhouette and Skew. We are also pleased to announce today that we executed a sale of our remaining biotech IP assets to Arctic Vision in July. Our promise on our first call was that we would pursue the monetization and resolution of certain no longer core assets, and that is now accomplished. From July 2025 through July 2026, in total, we extinguished $2.7 million of legacy biotech liabilities, not from us paying down liabilities with cash but from actively working with partners, including Arctic Vision, to release what we owed without cash consideration. With the past behind us, we are now solely a DeFi company. Now on to our Q2 results. Our Q2 adjusted gross profit grew 20% quarter-over-quarter from $960,000 to $1.2 million. 50% was earned in cash, and we achieved 2.2x base staking yield. The 20% quarterly growth rate in Q2 compares to 17% growth achieved in Q1 versus Q4. This quarter demonstrated the benefit of our 5 diversified DeFi income sources, where headwinds in some areas were offset by tailwinds in others, and the overall growth trajectory remains positive. I'll now go through each of those 5 segments. Starting with staking yield. In Q2, we earned $527,000 from staking our HYPE to our Kinetiq x Hyperion Validator. This was up 69% quarter-over-quarter, driven by the increase in the price of HYPE from an average of 30.8 over Q1 to 51.2 over Q2. Next, validator commissions. In Q2, we earned $42,000 in validator commissions from third-party tokens delegated to our validator, up 4% versus $40,000 last quarter. In Q2, consistent with Q1, we continue from a GAAP perspective to present our validating activities on a net basis in accordance with the treatment that we are agent of the validator. As Hyunsu mentioned, we recently announced a partnership with Blockdaemon, one of the largest institutional crypto platforms, where they have chosen us to be their staking partner on Hyperliquid. We continue to see multiple opportunities for validator growth driven by the products and services we are creating, plus demand from institutions for world-class validator infrastructure. In total in Q2, we earned about 11,000 HYPE tokens from staking and validating, in line with what we earned in Q1. Next, our yield enhancement strategies, which primarily monetize volatility on HYPE, including in our vaults with Rysk, generated $334,000 of adjusted gross profit in Q2, which is plus 58% quarter-over-quarter versus $211,000 in Q1. Our DeFi monetization segment captures a host of products and services we are building on Hyperliquid together with our partners. This quarter we had a 36% decline in DeFi monetization from $245,000 in Q1 to $158,000 in Q2, largely driven by the sunset of the USDH stablecoin announced in mid-May, resulting in our HAUS agreements with both Native Markets and Felix being terminated in June, and opening up 800,000 of our HYPE tokens to be redeployed into other business opportunities. While we still earned base staking yield on these 800,000 tokens, these wind-downs resulted in a Q2 decline in DeFi monetization. Despite this headwind, in June, we chose to announce that we stood by our existing guidance based on our robust pipeline to redeploy our HYPE. As outlined by Hyunsu, we have regained momentum since then. We have already redeployed 1 million HYPE tokens into new HAUS partnerships in Q3, and we expect our new deployments over time to position us better than before. And finally, ecosystem rewards generated $90,000 of adjusted gross profit in Q2 versus $150,000 in Q1. We stated previously that we expect the quarter-over-quarter change in ecosystem rewards to be volatile, given the unexpected timing of airdrops, token generation events and other rewards activity. However, this is now the third consistent quarter of activity in this segment, and it continues to be a core part of our Triple-Dip Strategy. The Q2 figure reflects 2 pieces: first, our receipt and subsequent sale of MAX tokens received in an airdrop; second, a onetime grant from Felix, denominated in USDC due to the sunset of USDH. We are also announcing that as part of the July HAUS agreement with Skew, we have a right in the future to 5% of Skew equity and 5% of tokens should they choose to pursue a Skew TGE. Our list of ecosystem positions we've accumulated over the past year continues to grow. In Q4, we received 1.92 million KNTQ tokens from Kinetiq. Since then, we have been liquid staking our KNTQ recently at annual yields exceeding 7% and have accrued over 40,000 additional KNTQ tokens thus far in 2026. Since we continue to earn Kinetiq points, we expect to be eligible for their next airdrop, which has been announced for Q4 this year. In Q1, we received 10 million HPL tokens from HyperLend as part of our various partnerships previously discussed. In Q1, we also gained the right to receive 1% future token or equity in Silhouette. We are also earning Rysk points from our vault activity and may become eligible for future Rysk tokens. And we expect this list to continue to grow as we deepen our partnerships and relationships across the Hyperliquid ecosystem. And as a reminder, we didn't pay anything for these tokens. We have only paid for HYPE, and we believe the upside we have to the broader Hyperliquid ecosystem is unique among any other U.S. public company. Moving on to our Q2 expenses. Operating expenses excluding stock-based compensation declined 21% quarter-over-quarter from $3.0 million in Q1 to $2.3 million in Q2. As a reminder, the Q2 figure of $2.3 million is about half the $4.3 million we spent in Q3 2025, our first quarter since adopting the new DeFi strategy. The reduced costs speak to our light operating model, offering strong earnings leverage. We substantially wound down all operations related to our legacy biotech segment in the second quarter. With the past behind us, we continue to be laser focused on all cost components as our DeFi businesses evolve and scale. On the treasury side, our gross HYPE tokens increased from 1.94 million in Q1 to 2.04 million in Q2. The price of HYPE increased from 36.6 at the end of Q1 to 65.0 in Q2. This compares to our aggregate purchase price on HYPE tokens of 39.7, meaning the value of our HYPE treasury at $133 million as of Q2 exceeded our cash basis of $81 million by approximately $52 million. Our net asset value, which adjusts our treasury value for net cash and debt, increased from $70 million as of Q1 to $134 million as of Q2. Treasury gains was $54.8 million in Q2 as the price of HYPE increased versus a gain of $21.5 million in Q1. In totality, Q2 net income of $31.0 million, another record for the company, compares to Q1 net income of $8.8 million. Q2 adjusted EBITDA of $53.7 million compares to Q1 adjusted EBITDA of $19.5 million. As with Q1, the primary Q2 reconciliation of net income to adjusted EBITDA is our HYPE liquid staking tokens, or LSTs, for which the GAAP carrying value is the low-watermark price of HYPE. If all our HYPE LSTs were converted back to HYPE at the end of Q2, we believe that would have increased our GAAP net income by approximately $33.2 million. Regarding our cash flows and cash position, as a DeFi company, we have been and expect to continue to be very active with on-chain stablecoin activity, which involves USDC, historically USDH, deposits into our vault, and potentially other activity in the future as we grow. However, stablecoin base balances and activities are not presented as GAAP cash, and this has caused some period-to-period volatility in our GAAP presentments of cash flows. Starting today, we are now also presenting 2 new non-GAAP metrics, adjusted net operating cash flow and adjusted net investing cash flow, with the goal of removing the volatility caused by our stablecoin forward operations. These are all more fully defined and reconciled in our earnings release and earnings supplement available online. Adjusted net operating cash flow was $2.1 million of outflows in Q2, which compares to $2.6 million outflows in Q1. Adjusted net investing cash flow was $6.2 million in Q2 versus $1.5 million in Q1 as we continue to grow our HYPE treasury position. Net cash provided by financing activities was $11.0 million in Q2, primarily from our May public offering, versus $6.6 million in Q1. As of Q2, we hold $11.8 million in cash, cash equivalents and stablecoins versus $9.1 million as of Q1. As of August 10, our common share count is approximately 15.5 million shares. Looking ahead, in our first earnings call under the new DeFi strategy in November 2025, along with our ambitious goal to create a new kind of operating company, we set out ambitious financial goals, which we continue to stand behind as we innovate and grow our businesses. We originally gave guidance of $4 million to $6 million of adjusted gross profit for 2026 and raised that guidance in May to $5 million to $7 million. In addition, we anticipate our adjusted net operating cash flow to flip positive by the end of the year, and that's what we have been communicating since day 1. We continue to be confident in achieving that guidance based on our delivery of consistent quarterly performance, including growing businesses, declining costs, and improving cash flows. We believe we have the right team, partners and resources and the right chosen blockchain in Hyperliquid to achieve these goals. Every day, we remain squarely focused on continued execution, driving value for shareholders over time while helping to build Hyperliquid into the blockchain to house all of finance. As Hyunsu said earlier, our model is no longer a concept that we ask investors to envision. It has become a reality that stands alone among public companies. We believe the results will continue to speak for themselves. With that, we look forward to answering your questions.